US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
CH686865A5
(de)
*
|
1994-06-15 |
1996-07-31 |
Gergely Gerhard |
Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
|
US5545628A
(en)
*
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
GB9525194D0
(en)
*
|
1995-12-12 |
1996-02-07 |
Zeneca Ltd |
Pharmaceutical composition
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US5955098A
(en)
*
|
1996-04-12 |
1999-09-21 |
Flemington Pharmaceutical Corp. |
Buccal non polar spray or capsule
|
GB9608719D0
(en)
*
|
1996-04-26 |
1996-07-03 |
Scherer Ltd R P |
Pharmaceutical compositions
|
CZ430598A3
(cs)
*
|
1996-06-28 |
1999-04-14 |
Novartis Ag |
Kapalný pesticidní prostředek
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US5788978A
(en)
*
|
1996-12-17 |
1998-08-04 |
Passeron; Eduardo Julio |
Injectable pulsatile ivermectin composition
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
WO1998047486A1
(fr)
*
|
1997-04-18 |
1998-10-29 |
Taisho Pharmaceutical Co., Ltd. |
Microemulsion
|
AR012627A1
(es)
*
|
1997-04-29 |
2000-11-08 |
Sherman Bernard Charles |
Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
|
US20030133974A1
(en)
*
|
1997-07-01 |
2003-07-17 |
Curatolo William John |
Encapsulated solution dosage forms of sertraline
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
WO1999006043A1
(en)
*
|
1997-07-29 |
1999-02-11 |
Pharmacia & Upjohn Company |
Self-emulsifying formulation for lipophilic compounds
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
AU4894697A
(en)
*
|
1997-10-01 |
1999-04-23 |
Flemington Pharmaceutical Corporation |
Buccal, polar and non-polar spray or capsule
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20040136914A1
(en)
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US6063762A
(en)
*
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
KR20010040646A
(ko)
*
|
1998-02-09 |
2001-05-15 |
블로닉, 조엘 |
위장관의 만성 염증성 질환의 치료방법
|
EP1079808B1
(de)
|
1998-05-29 |
2004-02-11 |
Skyepharma Canada Inc. |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
FR2782006B1
(fr)
*
|
1998-08-07 |
2002-04-19 |
Gattefosse Ets Sa |
Composition a liberation prolongee apte a former une micro-emulsion
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
JP3557579B2
(ja)
*
|
1998-09-11 |
2004-08-25 |
株式会社三協 |
ソフトカプセル剤
|
CZ20011739A3
(cs)
|
1998-11-20 |
2001-10-17 |
Rtp Pharma Inc. |
Dispergovatelné fosfolipidem stabilizované mikročástice
|
IL143580A0
(en)
|
1998-12-11 |
2002-04-21 |
Pharmasolutions Inc |
Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
|
EP1140036A2
(de)
*
|
1998-12-18 |
2001-10-10 |
Abbott Laboratories |
Neue formulierungen mit lipid regulierenden wirkstoffen
|
US6814977B1
(en)
|
1998-12-18 |
2004-11-09 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US7014864B1
(en)
|
1998-12-18 |
2006-03-21 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6838091B2
(en)
*
|
1998-12-18 |
2005-01-04 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
JP2002534370A
(ja)
|
1998-12-30 |
2002-10-15 |
デクセル リミテッド |
サイクロスポリンを送達するための分散可能な濃縮物
|
US6368622B2
(en)
|
1999-01-29 |
2002-04-09 |
Abbott Laboratories |
Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US6383517B1
(en)
|
1999-01-29 |
2002-05-07 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US20030026835A1
(en)
*
|
1999-02-15 |
2003-02-06 |
Sumitomo Pharmaceuticals Company Limited |
Tablets disintegrating rapidly in the oral cavity
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
CA2362728C
(en)
*
|
1999-03-24 |
2009-06-23 |
Fmc Corporation |
Improved aqueous solubility pharmaceutical formulations
|
US6616942B1
(en)
*
|
1999-03-29 |
2003-09-09 |
Soft Gel Technologies, Inc. |
Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
|
US6719999B2
(en)
|
1999-03-31 |
2004-04-13 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
WO2000057918A2
(en)
*
|
1999-03-31 |
2000-10-05 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
JP2003520767A
(ja)
*
|
1999-03-31 |
2003-07-08 |
アボット・ラボラトリーズ |
脂質調整剤を含む新規製剤
|
GB9907715D0
(en)
*
|
1999-04-01 |
1999-05-26 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6652880B1
(en)
|
1999-04-01 |
2003-11-25 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6372251B2
(en)
*
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030235595A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
ES2241663T3
(es)
*
|
1999-09-21 |
2005-11-01 |
Skyepharma Canada Inc. |
Composiciones particuladas modificadas superficialmente de substancias biologicamente activas.
|
WO2001030337A2
(en)
*
|
1999-10-22 |
2001-05-03 |
Orbon Corporation |
Ophthalmic formulation of dopamine antagonists
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6632429B1
(en)
*
|
1999-12-17 |
2003-10-14 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
US20050037073A1
(en)
*
|
2000-01-13 |
2005-02-17 |
Alpharx Inc. |
Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
|
GB0001449D0
(en)
*
|
2000-01-21 |
2000-03-08 |
Cortendo Ab |
Compositions
|
MXPA02009763A
(es)
*
|
2000-04-04 |
2003-03-27 |
Shionogi & Co |
Composiciones aceitosas las cuales contienen farmacos altamente solubles en grasa.
|
US6365181B1
(en)
|
2000-04-20 |
2002-04-02 |
Gattefosse Corporation |
Thixatropic gelatin carrier composition
|
AU6608701A
(en)
*
|
2000-06-21 |
2002-01-02 |
Audit Institute For Medical Services And Quality Assurance Gmbh |
Pharmaceutical preparations containing cyclosporines and neutral oils
|
US6623734B2
(en)
*
|
2000-06-22 |
2003-09-23 |
Soft Gel Technologies, Inc. |
Super absorption coenzyme Q10
|
AUPQ875700A0
(en)
*
|
2000-07-13 |
2000-08-03 |
Reflex Research Limited |
Combination compositions
|
US6491950B1
(en)
*
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
US20020036154A1
(en)
*
|
2000-08-10 |
2002-03-28 |
Ramaswamy Murari |
Solid pharmaceutical dosage formulation of hydrophobic drugs
|
US20070053895A1
(en)
*
|
2000-08-14 |
2007-03-08 |
Fallon Joan M |
Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US8030002B2
(en)
|
2000-11-16 |
2011-10-04 |
Curemark Llc |
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
GB0101198D0
(en)
|
2001-01-17 |
2001-02-28 |
Scherer Technologies Inc R P |
Ingestible compositions containing an odoriferous oil
|
WO2002069936A2
(en)
*
|
2001-03-02 |
2002-09-12 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical composition of ibuprofen
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
WO2002072150A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
WO2002080678A1
(en)
|
2001-04-03 |
2002-10-17 |
Schering Corporation |
Antifungal composition with enhanced bioavailability
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
JP2004532847A
(ja)
*
|
2001-04-20 |
2004-10-28 |
ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア |
疎水性薬物のためのミセル薬物送達システム
|
AUPR510001A0
(en)
*
|
2001-05-18 |
2001-06-14 |
Jupitar Pty Ltd |
Formulation and method
|
CA2450238A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Galephar M/F |
Oral pharmaceutical composition containing a statin derivative
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
WO2003002095A1
(fr)
*
|
2001-06-28 |
2003-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Preparation d'une micro-emulsion de type huile-eau
|
EP1411861B1
(de)
*
|
2001-06-29 |
2012-04-04 |
Medgraft Microtech, Inc. |
Biologisch abbaubare injizierbare implantate und verwandte herstellungs- und verwendungsmethoden
|
US7737185B2
(en)
*
|
2001-07-09 |
2010-06-15 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene
|
CN1289075C
(zh)
*
|
2001-07-09 |
2006-12-13 |
佐纳根有限公司 |
富含反式克罗米酚的克罗米酚组合物的用途
|
US7173064B2
(en)
*
|
2001-07-09 |
2007-02-06 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US20050009762A1
(en)
*
|
2003-06-06 |
2005-01-13 |
Strobel Michael Albert |
Application of water and organic solvent soluble ivermectin for topical and oral use
|
GB0119480D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
US6488952B1
(en)
|
2001-08-28 |
2002-12-03 |
John P. Kennedy |
Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
|
FR2829028B1
(fr)
*
|
2001-08-29 |
2004-12-17 |
Aventis Pharma Sa |
Association d'un antagoniste du recepteur cb1 et d'un produit qui active la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de
|
US6479060B1
(en)
|
2001-09-04 |
2002-11-12 |
Healthpoint, Ltd. |
Elegant hydrogenated castor oil ointments
|
DE60225026T2
(de)
*
|
2001-09-10 |
2009-02-05 |
F. Hoffmann-La Roche Ag |
Ölige thixotrope zusammensetzungen
|
GB0125061D0
(en)
*
|
2001-10-18 |
2001-12-12 |
Norton Healthcare Ltd |
Pharmaceutical composition
|
US6462083B1
(en)
|
2001-11-13 |
2002-10-08 |
Sarfaraz K. Niazi |
Suppository base
|
US7588786B2
(en)
|
2001-11-14 |
2009-09-15 |
Jarrow Formulas, Inc. |
Eutectic-based self-nanoemulsified drug delivery system
|
EP1461044A4
(de)
*
|
2001-12-03 |
2007-06-13 |
Novacea Inc |
Pharmazeutische zusammensetzungen mit aktiven vitamin-d-verbindungen
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US8100844B2
(en)
*
|
2002-04-25 |
2012-01-24 |
Ultraflex Systems, Inc. |
Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
|
US20050287203A1
(en)
*
|
2002-05-08 |
2005-12-29 |
Nijs De H |
Formulation comprising testosteron undecanoate and castor oil
|
US6890558B2
(en)
*
|
2002-05-31 |
2005-05-10 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
US6855332B2
(en)
*
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
KR100533458B1
(ko)
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
GB2391471B
(en)
*
|
2002-08-02 |
2005-05-04 |
Satishchandra Punambhai Patel |
Pharmaceutical compositions
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
PL376792A1
(pl)
*
|
2002-10-23 |
2006-01-09 |
Glaxosmithkline Biologicals S.A. |
Sposoby szczepienia przeciwko malarii
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
TW200409644A
(en)
*
|
2002-12-04 |
2004-06-16 |
Bio Max Inc |
Improved carrier system for cyclosporin pharmaceutical compositions
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
WO2004062692A1
(en)
*
|
2003-01-13 |
2004-07-29 |
Solvay Pharmaceuticals B.V. |
Formulation of poorly water-soluble active substances
|
US7323206B1
(en)
|
2003-03-04 |
2008-01-29 |
B. Braun Medical Inc. |
Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
|
ES2496102T3
(es)
*
|
2003-03-28 |
2014-09-18 |
Sigmoid Pharma Limited |
Forma de dosificación oral sólida que contiene microcápsulas sin fisuras
|
US20040191207A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Lipari John M. |
Alpha-hydroxy acid ester drug delivery compositions and methods of use
|
GB0308732D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
GB0308734D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
EP1498123A1
(de)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Emulgierende Systeme enthaltend Azetidin Derivate
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
US20080089877A1
(en)
*
|
2003-08-14 |
2008-04-17 |
Udell Ronald G |
Super Absorption Coenzyme Q10
|
US7169385B2
(en)
*
|
2003-09-29 |
2007-01-30 |
Ronald G. Udell |
Solubilized CoQ-10 and carnitine
|
US8124072B2
(en)
|
2003-09-29 |
2012-02-28 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
US8105583B2
(en)
|
2003-09-29 |
2012-01-31 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
WO2005037251A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Amylin Pharmaceuticals, Inc. |
Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
|
FR2861261B1
(fr)
*
|
2003-10-22 |
2007-11-16 |
Adisseo France Sas |
Procede zootechnique pour l'administation d'un derive de vitamine e et formulation
|
FR2861992B1
(fr)
*
|
2003-11-10 |
2007-07-20 |
Sanofi Synthelabo |
Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
PT1530965E
(pt)
|
2003-11-11 |
2006-05-31 |
Udo Mattern |
Sistema de administracao de libertacao controlada de hormonas sexuais para aplicacao nasal
|
US8062664B2
(en)
*
|
2003-11-12 |
2011-11-22 |
Abbott Laboratories |
Process for preparing formulations of lipid-regulating drugs
|
CN1257711C
(zh)
*
|
2003-12-05 |
2006-05-31 |
石药集团中奇制药技术(石家庄)有限公司 |
丁苯酞软胶囊及其制备工艺
|
EP1728505B1
(de)
*
|
2004-03-24 |
2014-06-04 |
Takeda Pharmaceutical Company Limited |
Zubereitung mit erhöhtem gehalt
|
US20060177512A1
(en)
*
|
2004-04-05 |
2006-08-10 |
Yihong Qiu |
Process for preparing formulations of lipid-regulating drugs
|
US8241670B2
(en)
*
|
2004-04-15 |
2012-08-14 |
Chiasma Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
US8758821B2
(en)
|
2004-05-04 |
2014-06-24 |
Hormos Medical Ltd. |
Oral formulations of ospemifene
|
MXPA06012758A
(es)
|
2004-05-04 |
2007-01-16 |
Hormos Medical Ltd |
Novedosas formulaciones orales de ospemifeno.
|
US8075910B2
(en)
*
|
2004-05-20 |
2011-12-13 |
Pbm Pharmaceuticals, Inc. |
Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
|
WO2005120517A1
(en)
*
|
2004-06-07 |
2005-12-22 |
Strides Arcolab Limited |
Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
|
MX2007000050A
(es)
*
|
2004-07-14 |
2007-07-10 |
Repros Therapeutics Inc |
Trans-clomifeno para el tratamiento de hipertrofia de prostata benigna, cancer de prostata, hipogonadismo, trigliceridos elevados y colesterol elevado.
|
US20080044538A1
(en)
*
|
2004-08-31 |
2008-02-21 |
Akzo Nobel N.V. |
Method For Pigment Solubilization, A pigment Composition And Its Use
|
JPWO2006033435A1
(ja)
*
|
2004-09-24 |
2008-05-15 |
株式会社ハイレックスコ−ポレ−ション |
生体硬組織または軟組織誘導性スカフォールド材料
|
WO2006035418A2
(en)
*
|
2004-09-27 |
2006-04-06 |
Sigmoid Biotechnologies Limited |
Microcapsules comprising a methylxanthine and a corticosteroid
|
US8026281B2
(en)
*
|
2004-10-14 |
2011-09-27 |
Lupin Atlantis Holdings, S.A. |
Treating metabolic syndrome with fenofibrate
|
CN101065115A
(zh)
*
|
2004-11-24 |
2007-10-31 |
默克公司 |
取代酰胺的液体和半固体口服药物制剂
|
EA014420B1
(ru)
*
|
2004-12-06 |
2010-12-30 |
Релайэнт Фармасьютикалз, Инк. |
Омега-3 жирные кислоты и дислипидемический агент для липидной терапии
|
AU2005314197A1
(en)
*
|
2004-12-06 |
2006-06-15 |
Reliant Pharmaceuticals, Inc. |
Stable compositions of fenofibrate with fatty acid esters
|
US20060140820A1
(en)
|
2004-12-28 |
2006-06-29 |
Udo Mattern |
Use of a container of an inorganic additive containing plastic material
|
NZ556499A
(en)
*
|
2005-02-04 |
2011-02-25 |
Repros Therapeutics Inc |
Methods and materials with trans-clomiphene for the treatment of male infertility
|
MX2007011031A
(es)
*
|
2005-03-08 |
2008-04-21 |
Reliant Pharmaceuticals Inc |
Tratamiento con estatina y acidos grasos omega-3 y un producto de combinacion de los mismos.
|
US8673351B2
(en)
|
2005-03-21 |
2014-03-18 |
Ivax Pharmaceuticals S.R.O. |
Crystallization inhibitor and its use in gelatin capsules
|
BRPI0609389A2
(pt)
*
|
2005-03-22 |
2010-03-30 |
Repros Therapeutics Inc |
tablete, composição e respectivos usos
|
US7276113B2
(en)
*
|
2005-04-07 |
2007-10-02 |
U.S. Cosmetics Corporation |
Self-emulsifying pigments
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
EP2985026B1
(de)
*
|
2005-04-15 |
2022-08-03 |
Clarus Therapeutics, Inc. |
Systeme zur pharmazeutischen verabreichung hydrophober wirkstoffe und zusammensetzungen damit
|
WO2006119660A1
(en)
*
|
2005-05-11 |
2006-11-16 |
Givaudan Sa |
Encapsulation method
|
EP1893182B8
(de)
*
|
2005-05-26 |
2012-04-04 |
Teva Women's Health, Inc. |
Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
|
JP4889262B2
(ja)
*
|
2005-08-19 |
2012-03-07 |
理研ビタミン株式会社 |
脂溶性薬剤組成物
|
US20080058282A1
(en)
|
2005-08-30 |
2008-03-06 |
Fallon Joan M |
Use of lactulose in the treatment of autism
|
WO2007034511A2
(en)
*
|
2005-09-22 |
2007-03-29 |
Ramachandran Radhakrishnan |
Novel solubility enhancer and use thereof
|
US20070104780A1
(en)
*
|
2005-10-25 |
2007-05-10 |
Lipari John M |
Formulation comprising a drug of low water solubility and method of use thereof
|
EP1942872A2
(de)
*
|
2005-11-04 |
2008-07-16 |
Eastman Chemical Company |
Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen
|
WO2007067593A2
(en)
|
2005-12-05 |
2007-06-14 |
Merck & Co., Inc. |
Self-emulsifyng formulations of cetp inhibitors
|
CA2649895C
(en)
*
|
2006-04-19 |
2013-03-26 |
Novadel Pharma Inc. |
Stable hydroalcoholic oral spray formulations and methods
|
EP2023957A2
(de)
*
|
2006-06-07 |
2009-02-18 |
Morton Grove Pharmaceuticals, Inc. |
Orale flüssige loratadinformulierungen und verfahren
|
KR101390695B1
(ko)
*
|
2006-08-01 |
2014-04-30 |
오츠카 세이야쿠 가부시키가이샤 |
약리 활성 물질의 흡수성이 개선된 의약 조성물
|
CA2558202A1
(en)
*
|
2006-09-14 |
2006-11-23 |
Reinhold W. Vieth |
Vitamin d compositions and method of administration to infants
|
CA2664427C
(en)
|
2006-10-04 |
2012-06-05 |
M & P Patent Aktiengesellschaft |
Controlled release delivery system for nasal application of neurotransmitters
|
KR101441459B1
(ko)
*
|
2006-10-24 |
2014-09-18 |
헬신 헬쓰케어 에스.에이. |
안정성 및 생체이용률이 개선된 염산 팔로노세트론을 포함하는 연질 캡슐
|
WO2008079295A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Novadel Pharma Inc. |
Stable anti-nausea oral spray formulations and methods
|
EP1961412A1
(de)
*
|
2006-12-27 |
2008-08-27 |
LEK Pharmaceuticals D.D. |
Selbstmikroemulgierende Arzneimittelabgabesysteme
|
US8343541B2
(en)
|
2007-03-15 |
2013-01-01 |
Soft Gel Technologies, Inc. |
Ubiquinol and alpha lipoic acid compositions
|
US10265265B2
(en)
*
|
2007-03-15 |
2019-04-23 |
Drug Delivery Solutions Limited |
Topical composition
|
DE102007015701A1
(de)
*
|
2007-03-19 |
2008-09-25 |
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh |
Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
|
EP2066309B1
(de)
|
2007-04-04 |
2012-08-29 |
Sigmoid Pharma Limited |
Orale pharmazeutische zusammensetzung
|
EP2586428B1
(de)
*
|
2007-04-26 |
2023-11-08 |
Sublimity Therapeutics Limited |
Herstellung mehrerer Minikapseln
|
JP2010526053A
(ja)
*
|
2007-05-01 |
2010-07-29 |
シグモイド・ファーマ・リミテッド |
ニモジピン医薬組成物
|
BRPI0811430A2
(pt)
*
|
2007-05-10 |
2015-06-23 |
Novadel Pharma Inc |
Composições anti-insônia e processos
|
EP2008651A1
(de)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
Biologisch erodierbares Patch
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
EP2044930A1
(de)
*
|
2007-10-01 |
2009-04-08 |
Nestec S.A. |
Zusammensetzung zur Steuerung Lipase-katalysierter Reaktionen
|
ES2718912T3
(es)
|
2007-10-16 |
2019-07-05 |
Repros Therapeutics Inc |
Trans-clomifeno para el tratamiento de la diabetes en hombres hipogonadales
|
US7985325B2
(en)
*
|
2007-10-30 |
2011-07-26 |
Novellus Systems, Inc. |
Closed contact electroplating cup assembly
|
US20090162517A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Chilled Nutritional Emulsions
|
US20090162522A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Induced Viscosity Nutritional Emulsions Comprising A Carbohydrate-Surfactant Complex
|
US20090162494A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Method of Making Chilled Nutritional Emulsions
|
US8658163B2
(en)
|
2008-03-13 |
2014-02-25 |
Curemark Llc |
Compositions and use thereof for treating symptoms of preeclampsia
|
US8084025B2
(en)
|
2008-04-18 |
2011-12-27 |
Curemark Llc |
Method for the treatment of the symptoms of drug and alcohol addiction
|
US20090324730A1
(en)
*
|
2008-06-26 |
2009-12-31 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of complex regional pain syndrome
|
US9320780B2
(en)
|
2008-06-26 |
2016-04-26 |
Curemark Llc |
Methods and compositions for the treatment of symptoms of Williams Syndrome
|
EP2318035B1
(de)
|
2008-07-01 |
2019-06-12 |
Curemark, Llc |
Verfahren und zusammensetzungen zur behandlung von symptomen von neurologischen und geistesstörungen
|
US10776453B2
(en)
*
|
2008-08-04 |
2020-09-15 |
Galenagen, Llc |
Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
|
EP3210474B1
(de)
*
|
2008-09-17 |
2020-11-18 |
Chiasma, Inc. |
Pharmazeutische zusammensetzungen mit polypeptiden und zugehörige abgabeverfahren
|
US20100092447A1
(en)
|
2008-10-03 |
2010-04-15 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of prion diseases
|
JP5613396B2
(ja)
*
|
2008-10-22 |
2014-10-22 |
参天製薬株式会社 |
腸管吸収性を改善する医薬組成物
|
FR2937537A1
(fr)
|
2008-10-29 |
2010-04-30 |
Centre Nat Rech Scient |
Nanoparticules de statine
|
US9084784B2
(en)
|
2009-01-06 |
2015-07-21 |
Curelon Llc |
Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
|
EP3064217B1
(de)
|
2009-01-06 |
2018-04-18 |
Galenagen, LLC |
Zusammensetzungen enhaltend protease, amylase and lipase zur verwendung in der behandlung von staphylococcus aureus-infektionen
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
CA3065860A1
(en)
|
2009-03-09 |
2010-09-16 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
|
WO2010117873A2
(en)
|
2009-04-06 |
2010-10-14 |
Banner Pharmacaps, Inc. |
Progesterone solutions for increased bioavailability
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
US20100297194A1
(en)
*
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US8362013B2
(en)
*
|
2009-04-30 |
2013-01-29 |
Abbvie Inc. |
Salt of ABT-263 and solid-state forms thereof
|
US20100280031A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Paul David |
Lipid formulation of apoptosis promoter
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
US8728516B2
(en)
*
|
2009-04-30 |
2014-05-20 |
Abbvie Inc. |
Stabilized lipid formulation of apoptosis promoter
|
SI2432455T1
(sl)
|
2009-05-18 |
2015-04-30 |
Sigmoid Pharma Limited |
Sestava, obsegajoäśa oljne kapljice
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
TWI532484B
(zh)
*
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
TWI540132B
(zh)
*
|
2009-06-08 |
2016-07-01 |
亞培公司 |
Bcl-2族群抑制劑之口服醫藥劑型
|
RU2012101214A
(ru)
|
2009-06-16 |
2013-07-27 |
Пфайзер Инк. |
Лекарственные формы апиксабана
|
EP2464341B1
(de)
|
2009-08-12 |
2022-07-06 |
Sublimity Therapeutics Limited |
Immunmodulatorische zusammensetzungen mit einer polymermatrix und einer ölphase
|
WO2011050135A1
(en)
|
2009-10-21 |
2011-04-28 |
Curemark Llc |
Methods and compositions for the prevention and treatment of influenza
|
EP2515883A4
(de)
*
|
2009-12-22 |
2013-07-17 |
Abbvie Inc |
Abt-263-kapsel
|
MX2012007229A
(es)
|
2009-12-22 |
2012-07-30 |
Leo Pharma As |
Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
|
EP2682111A1
(de)
|
2009-12-31 |
2014-01-08 |
Differential Drug Development Associates LLC |
Modulation der Löslichkeit, der Stabilität, der Absorption, des Stoffwechsels und des pharmakokinetischen Profils lipophiler Wirkstoffe mithilfe von Sterolen
|
PL2523666T3
(pl)
*
|
2010-01-14 |
2016-06-30 |
Asarina Pharma Ab |
Kompozycja farmaceutyczna zawierająca 3-beta-hydroksy-5-alfa-pregnan-20-on o ulepszonych właściwościach przechowywania i rozpuszczalności
|
CA2690490C
(en)
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
US20110218209A1
(en)
*
|
2010-03-06 |
2011-09-08 |
Paul Daniel Yered |
Nutrient delievry drug composition
|
DK2558073T3
(en)
*
|
2010-04-12 |
2014-12-08 |
Clarus Therapeutics Inc |
ORAL testosterone ester FORMULATIONS AND METHODS FOR TREATMENT OF testosterone deficiency INCLUDING THE SAME
|
CN103705462B
(zh)
*
|
2010-04-12 |
2016-08-31 |
克劳拉斯医疗有限公司 |
口服睾酮酯制剂以及包含其的治疗睾酮缺乏症的方法
|
US9375437B2
(en)
|
2010-06-18 |
2016-06-28 |
Lipocine Inc. |
Progesterone containing oral dosage forms and kits
|
MY158809A
(en)
*
|
2010-09-22 |
2016-11-15 |
Craun Res Sdn Bhd |
Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3337B1
(ar)
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
GB2488788B
(en)
*
|
2011-03-07 |
2013-07-10 |
Natco Pharma Ltd |
Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
|
WO2012123515A1
(en)
|
2011-03-14 |
2012-09-20 |
Drug Delivery Solutions Limited |
An ophthalmic composition
|
CN103619348B
(zh)
|
2011-04-21 |
2016-10-26 |
柯尔马克有限责任公司 |
用于治疗神经精神障碍的化合物
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
WO2013034436A1
(de)
*
|
2011-09-08 |
2013-03-14 |
Hexal Ag |
Pharmazeutische zusammensetzung zur oralen darreichung mit einem statin
|
CA2850187C
(en)
|
2011-09-29 |
2021-12-07 |
Plx Pharma Inc. |
Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN102525917B
(zh)
*
|
2012-01-04 |
2014-06-18 |
四川百利药业有限责任公司 |
一种尼莫地平胶束注射剂及其制备方法
|
EP2827839B1
(de)
|
2012-03-20 |
2019-02-27 |
Particle Dynamics International, LLC |
Dosierungsform auf basis eines gelierungsmittels
|
US10350278B2
(en)
|
2012-05-30 |
2019-07-16 |
Curemark, Llc |
Methods of treating Celiac disease
|
EP2858629A1
(de)
|
2012-06-08 |
2015-04-15 |
Leo Laboratories Limited |
Topische gelzusammensetzung mit einem ingenolderivat und einer lösungsmittelmischung
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
EP2861073B1
(de)
*
|
2012-06-18 |
2021-04-14 |
TherapeuticsMD, Inc. |
Lösliche östradiolkapsel zur vaginalen einführung
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
DE102012105512A1
(de)
*
|
2012-06-25 |
2014-04-24 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur verlängerten Freisetzung von Wirkstoffen
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
JP2015535283A
(ja)
|
2012-11-02 |
2015-12-10 |
レプロス セラピューティクス インコーポレイティド |
癌療法における使用のためのトランス−クロミフェン
|
US9682148B2
(en)
|
2012-12-20 |
2017-06-20 |
Solural Pharma ApS |
Solid oral dosage form of testosterone derivative
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
WO2014128564A2
(en)
|
2013-02-21 |
2014-08-28 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of cetp inhibitors
|
WO2014143127A1
(en)
|
2013-03-15 |
2014-09-18 |
Differential Drug Development Associates Llc |
Emulsion formulations
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
CN103257192B
(zh)
*
|
2013-05-08 |
2014-12-24 |
北京满格医药科技有限公司 |
一种软胶囊的溶出度测定方法
|
US10201549B2
(en)
*
|
2013-06-14 |
2019-02-12 |
Professional Compounding Centers Of America (Pcca) |
Testosterone combined with anastrozole injection solutions
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
EP2878311A1
(de)
*
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
|
US10245273B2
(en)
|
2013-12-26 |
2019-04-02 |
Clarus Therapeutics, Inc. |
Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
WO2015184173A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
CN106456782B
(zh)
*
|
2014-06-17 |
2020-02-18 |
默沙东有限责任公司 |
十一酸睾酮的稳定制剂
|
WO2015193380A2
(en)
*
|
2014-06-19 |
2015-12-23 |
Solural Pharma ApS |
Solid oral dosage form of lipophilic compounds
|
RU2016141135A
(ru)
|
2014-07-29 |
2018-08-28 |
Терапьютиксмд, Инк. |
Трансдермальный крем
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
CA2966801A1
(en)
|
2014-11-07 |
2016-05-12 |
Sigmoid Pharma Limited |
Compositions comprising cyclosporin
|
MA41462A
(fr)
|
2015-02-03 |
2021-05-12 |
Chiasma Inc |
Méthode de traitement de maladies
|
JP2018513693A
(ja)
*
|
2015-03-25 |
2018-05-31 |
ベネミルク オーワイBenemilk Oy |
ルーメンバイパス動物飼料組成物及びそれを作製する方法
|
WO2016164770A1
(en)
*
|
2015-04-10 |
2016-10-13 |
Bioresponse, L.L.C. |
Self-emulsifying formulations of dim-related indoles
|
WO2016187355A1
(en)
*
|
2015-05-20 |
2016-11-24 |
Glaukos Corporation |
Therapeutic drug compositions and implants for delivery of same
|
MX2017015238A
(es)
|
2015-05-28 |
2018-02-19 |
Dr Reddy´S Laboratories Ltd |
Composicion oral de celecoxib para tratamiento de dolor.
|
US20170035781A1
(en)
|
2015-06-22 |
2017-02-09 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017156183A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
US10064855B2
(en)
|
2016-03-08 |
2018-09-04 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
AU2017239679A1
(en)
*
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173044A1
(en)
*
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017184881A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|
MX2020005442A
(es)
|
2017-11-27 |
2022-03-30 |
Umecrine Cognition Ab |
FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
|
US11607384B2
(en)
*
|
2017-12-08 |
2023-03-21 |
Western University Of Health Sciences |
Lipid emulsified drug delivery systems for chemoprevention and treatment
|
CN110013467B
(zh)
*
|
2018-01-10 |
2021-09-17 |
上海汉都医药科技有限公司 |
一种固体微粒及其制备方法和含其的药物组合物
|
EP3542788A1
(de)
|
2018-03-19 |
2019-09-25 |
MC2 Therapeutics Limited |
Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
|
US11266615B2
(en)
|
2018-06-08 |
2022-03-08 |
Harrow Ip, Llc |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
WO2019236857A1
(en)
*
|
2018-06-08 |
2019-12-12 |
Harrow Health, Inc. |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
CA3116298A1
(en)
|
2018-10-15 |
2020-04-23 |
Cipla Limited |
Pharmaceutical formulation
|
EA202192793A1
(ru)
*
|
2019-04-11 |
2022-01-12 |
Ар.Пи. ШЕРЕР ТЕКНОЛОДЖИЗ, ЭлЭлСи |
Композиция для пероральной доставки белков, пептидов и малых молекул со слабой проницаемостью
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
MX2022011743A
(es)
|
2020-03-26 |
2022-12-08 |
Plx Opco Inc |
Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos.
|
US11541009B2
(en)
|
2020-09-10 |
2023-01-03 |
Curemark, Llc |
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
|
US11077134B1
(en)
|
2020-11-10 |
2021-08-03 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11638714B2
(en)
|
2020-11-10 |
2023-05-02 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
US11337987B1
(en)
|
2021-05-07 |
2022-05-24 |
Lipocine Inc. |
Compositions and methods for treating central nervous system disorders
|